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This study aimed to quantify the effect of age, time since last infection, and infection history on the rate of
respiratory syncytial virus infection and the effect of age and infection history on the risk of respiratory syncytial
virus disease. A birth cohort of 635 children in Kilifi, Kenya, was monitored for respiratory syncytial virus infec-
tions from January 31, 2002, to April 22, 2005. Predictors of infection were examined by Cox regression and
disease risk by binomial regression. A total of 598 respiratory syncytial virus infections were identified (411
primary, 187 repeat), with 409 determined by antigen assay and 189 by antibody alone (using a “most pragmatic”
serologic definition). The incidence decreased by 70% following a primary infection (adjusted hazard
ratio = 0.30, 95% confidence interval: 0.21, 0.42; P < 0.001) and by 59% following a secondary infection (hazard
ratio = 0.41, 95% confidence interval: 0.22, 0.73; P = 0.003), for a period lasting 6 months. Relative to the age
group <6 months, all ages exhibited a higher incidence of infection. A lower risk of severe disease following
infection was independently associated with increasing age (P < 0.001) but not reinfection. In conclusion,
observed respiratory syncytial virus incidence was lowest in the first 6 months of life, immunity to reinfection was
partial and short lived, and disease risk was age related.
birth cohort; estimation; incidence; reinfection; respiratory syncytial virus; risk
Abbreviations: ADI, antigen-determined infection; CI, confidence interval; CYO, child-years of observation; HR, hazard ratio;
log10(AU), logarithm (base 10)-transformed arbitrary units; LRTI, lower respiratory tract infection; SDI, serologically determined
infection.
Respiratory syncytial virus is the major viral pathogen
associated with lower respiratory tract infection (LRTI)
worldwide (1, 2). The development of an effective vaccine
and of strategies for intervention requires a full understand-
ing of the virus-host interaction. Respiratory syncytial virus
is characterized by recurrent epidemics (3–5), repeated rein-
fection throughout life (6–8), and age-related incidence of
severe disease (6, 9–11). The epidemic nature of respiratory
syncytial virus suggests the development of immunity to
infection that constrains continued transmission. However,
repeated reinfections argue for the absence or loss of immu-
nity to reinfection. This apparent paradox can be reconciled
by invoking combinations of partial and waning immunity
to reinfection (12–14). Evidence suggests that primary in-
fection results in the most severe disease and that reinfec-
tions have lower risk of disease (6), although some studies
show no evidence for decrease in risk from second as
opposed to further reinfections (7, 11). However, the effect
of infection history is confounded by age as severity de-
creases with age (15–17) as reinfections occur, by deﬁni-
tion, in older individuals. A high incidence of respiratory
syncytial virus disease in infants (10, 11) occurs despite the
passive transfer of maternal speciﬁc immunity (18).
These observations deﬁne a set of unresolved questions
on the natural history of respiratory syncytial virus. First, to
what degree does infection confer immunity to reinfection
794 Am J Epidemiol. 2012;176(9):794–802
American Journal of Epidemiology
© The Author 2012. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://
creativecommons.org/licenses/by-nc/3.0), which permits unrestricted reuse, distribution, and reproduction in any medium, provided
the original work is properly cited.
Vol. 176, No. 9
DOI: 10.1093/aje/kws257
Advance Access publication:
October 11, 2012
and for how long? Second, in what way does the rate of
infection vary with increasing age, and how does this inﬂu-
ence the observed age-related pattern of disease occur-
rence? Third, how do the 2 factors of age and past
exposure inﬂuence the risk of disease?
These questions are addressed by using data from a large
birth cohort closely monitored for respiratory syncytial
virus infections and associated disease (10, 18–20). The
present analysis incorporates unpublished data on repeated
measurements of respiratory syncytial virus-speciﬁc immu-
noglobulin G with commensurate increase in diagnostic
sensitivity. The infant antibody response to respiratory syn-
cytial virus is known to be inhibited to various degrees in
the presence of maternal speciﬁc antibodies (21) and to
decay following infection (22), making it problematic to
determine infections serologically. Using a novel approach,
we addressed this problem by deﬁning a set of deﬁnitions
by which to ascribe respiratory syncytial virus infections.
MATERIALS AND METHODS
Data source
The data are from a birth cohort study conducted in a
rural district of coastal Kenya over the period 2002–2005
(10, 18, 19, 23–25). The study location experiences a tropi-
cal climate with twice yearly rains from April to July and
from October to December. The population comprises pre-
dominantly subsistence farmers, has a demographic growth
rate of 3.1% per annum, and ∼18% are aged <5 years (26).
The district hospital is located within Kiliﬁ town, 60 km
north of Kenya’s main port of Mombasa. The birth cohort
was recruited over 2 calendar years with 338 enrolled
between January 31, 2002, and May 31, 2002, and 297 en-
rolled between December 3, 2002, and May 13, 2003.
Study participants were recruited in the maternity ward or
at the maternal and child health clinic within 2 weeks of
birth, at Kiliﬁ District Hospital, after written informed
consent for participation was obtained from the mother.
Cases of symptomatic respiratory syncytial virus were iden-
tiﬁed through home visits that were weekly during epidem-
ics of this virus and monthly otherwise and through Kiliﬁ
District Hospital outpatient clinic attendance or inpatient
admission. Nasopharyngeal washes were collected from
children exhibiting mild-through-severe symptoms of acute
respiratory infection. Children with acute cough or difﬁ-
culty in breathing and fast breathing for age were diagnosed
as having mild LRTI; those with acute cough or difﬁculty
in breathing and one or more of lower chest wall indrawing,
hypoxia (<90% pO2), or impaired consciousness were diag-
nosed as having severe LRTI. Blood samples were collected
at birth (cord blood) in the case of maternity ward deliver-
ies and at approximately 3-month intervals for all recruits
until the end of follow-up. Sera were stored at −80°C. Chil-
dren were lost to follow-up through death, migration,
refusal to continue, or end of the study. The study contin-
ued until children had experienced 3 respiratory syncytial
virus epidemics, ending April 22, 2005. Ethics clearance
was obtained from the Kenya National Ethics Review
Board and from the Coventry Research Ethics Committee,
United Kingdom.
Nasal specimens were screened for the presence of respi-
ratory syncytial virus antigen by immunoﬂuorescence
antibody test. Sera were assayed for respiratory syncytial
virus-speciﬁc immunoglobulin G by using crude respiratory
syncytial virus A2 strain lysate as the solid phase in an in-
direct enzyme-linked immunosorbent assay, and the absor-
bance readings were quantiﬁed against a serially diluted
high positive pool of sera and expressed as log (base 10)-
transformed arbitrary units (log10(AU)) (20, 27, 28). Previous
work established seropositive status as log10(AU)≥ 1.5 (18).
Definitions of respiratory syncytial virus infections
Two types of mutually exclusive infections were re-
solved. First, an antigen-determined infection (ADI) was
deﬁned as an immunoﬂuorescence antibody test-positive
nasal specimen. Second, a serologically determined infec-
tion (SDI) was deﬁned by a change in serologic status
between 2 serum samples that was independent of either an
ADI or another SDI. The possible serologic changes and
relation to ADI are schematically depicted in Figure 1 and
deﬁned in Table 1. Each consecutive pair of serum samples
from the same individual collected at times s1 and s2 with
antibody titers Ms1 and Ms2 were compared. An SDI was
considered if there was a seroconversion (i.e., Ms1 < 1.5
log10(AU) and Ms2≥ 1.5 log10(AU)) or if there was a sufﬁ-
cient boost to antibody titer (i.e., Ms2−Ms1≥ Z). There
were 2 reasons why such changes might not be considered
an SDI. First, the serum samples were taken too far apart,
so that the existence and timing of an infection were vague,
and consequently the criterion that s1− s2 < X was various-
ly applied. Second, the antibody change might have been
related to a known ADI, either if an ADI was bracketed by
the samples or if the ﬁrst sample was too close to the previ-
ous ADI such that the observed antibody boost should be
attributed to that infection. If an ADI occurred in the inter-
val (s1− Y, s2), then the antibody change was ascribed to
that ADI. If there was a sufﬁcient change in antibody titer
and the 2 additional criteria were passed, then an SDI was
deemed to have occurred, and the time of an SDI for analy-
sis was set at the date of s2. The proportion of ADI detect-
able by serology was taken as a measure of the sensitivity
of SDI detection.
Three groups of rules, termed “most liberal,” “most prag-
matic,” and “most conservative” (Table 1), were selected to
explore the effect of the uncertainty associated with deﬁn-
ing SDI. The most conservative rules deﬁned SDI with
high speciﬁcity but low sensitivity. Consequently, samples
had to be close (<X = 100 days), far from a previous ADI
(>Y = 200 days, which generally put an ADI and subse-
quent SDI in separate epidemics), the rise in titer dramatic
(≥Z = 10 fold = 1.000), and seroconversions (without a
boost of 10 fold or greater) were ignored. The most liberal
rules deﬁned SDI with low speciﬁcity but a high sensitivity.
Consequently, there was no criterion on sample interval,
time after the previous ADI was shorter (>Y = 50 days), the
required antibody boost was small (≥Z = 2 fold = 0.301), and
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Figure 1. Schema representing criteria for defining a serologic change that forms the basis of serologically determined infections of a birth
cohort of 635 children in Kilifi, Kenya, monitored over the period from January 31, 2002, to April 22, 2005. Three types of possibilities are
described, each consisting of an “acute” (circle) and a “convalescent” (square) antibody measurement, occurring at time s1 and s2 days,
respectively, and in relation to an antigen-determined infection (ADI) at a previous time sa. The division between seropositive and seronegative
antibody levels is shown as 1.5 log10(AU), arbitrary antibody units; X, threshold days between the dates of 2 sequential antibody results, s2− s1;
Z, threshold rise in antibody level between s1 and s2 (Ms2−Ms1); Y, threshold days among occurrence of ADI, sa, and first sample date s1;
seroconversion, seronegative to seropositive among s1 and s2, Ms1 < 1.5 log10(AU), and Ms2≥ 1.5 log10(AU) (A). Boost: minimal antibody
level rise between s1 and s2: Ms2−Ms1≥ Z (B and C). The serologically determined infection rules considered are defined as most
conservative: Z = 10 fold and (X = 100 and Y = 200); most pragmatic: (seroconversion | Z = 4 fold) and (X = 120 and Y = 50); and most liberal:
(seroconversion | Z = 2 fold and Y = 50).
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seroconversions were included. The most pragmatic rules
deﬁned SDI on the basis of the intermediate sample inter-
val (<X = 120 days), the same spacing after the previous
ADI as the most liberal deﬁnition (>Y = 50 days),
the conventional antibody boost for deﬁning infection
(≥Z = 4 fold = 0.602), and inclusion of seroconversion.
The choices of X, Y, and Z were made for the following
reasons. Antibody data were collected at intervals of
between 90 and 120 days, giving approximate limits to the
values of X chosen. Values of Y of <50 days between the
last ADI and the ﬁrst antibody measurement in any seroe-
vent were unreliable, because antibody titers were
commonly seen to continue to rise for several weeks after
an infection. A 4-fold increase in antibody titer applied to
the most pragmatic rule is conventional for the antibody
change deﬁning infection, and 2-fold and 10-fold increases
were chosen as representing extreme deﬁnitions.
Measures of the performance of each of the 3 classes of
SDI are shown in Table 2. The most conservative deﬁnition
was of low sensitivity (21%) when compared with the ADI
(i.e., “gold standard” deﬁnition of a respiratory syncytial
virus infection). The most liberal deﬁnition captured most
ADI (92% sensitivity). The most pragmatic classiﬁcation
gave intermediate sensitivity (52%). The results presented
are based primarily on the use of the most pragmatic rule,
and data derived from the most conservative rules and the
most liberal rules are used to check the robustness of
results.
Statistical analysis
Rates of infection were modeled by Cox regression (29).
A “failure” was deﬁned as respiratory syncytial virus infec-
tion indicated by an ADI or an SDI initially using the most
pragmatic deﬁnition. The “observation time” for each child
was days from the date of recruitment to the last visit of the
study (right censored because of the end of the study) or
loss to follow-up or death. The Efron approximation was
used to account for several infections occurring on the
same day (30). To allow for dependence between repeat in-
fections in the same individual, robust variance estimates
(Huber-White sandwich estimator) are reported (30). To
account for the time-dependent incidence of respiratory
syncytial virus, calendar time was adopted as analysis time,
which enabled modeling the baseline hazard of infection as
a nonparametric function of calendar time (31). The model
was assessed for any violation of the proportional hazards
assumption by using the Schoenfeld test. The relation
between disease risk and age class, by infection history,
was assessed by using the χ2 test for trend (age categories:
0–5 months, 6–11 months, 12–17 months, 18–23 months,
and ≥24 months). Adjusted risk ratios were obtained by
binomial regression with robust standard errors. All data
Table 2. Summary Table of Outcomes for Each Class of Infection (ADI or SDI) of a Birth Cohort of 635 Children in Kilifi, Kenya, Monitored
Over the Period From January 31, 2002, to April 22, 2005a
Rule No. of ADIs Detectedby Serology
No. of ADIs
Detectable
Sensitivity of SDI
Detection, %
No. of
SDIs
Total Infections
(ADI + SDI)
No. of Children Infected
at Least Once
No serology (ADI
only)
N/A N/A N/A N/A 409 326
Most
conservative
73 341 21.4 67 476 355
Most liberal 332 363 91.5 382 791 464
Most pragmatic 189 363 52.1 189 598 411
Abbreviations: ADI, antigen-determined infection; AU, arbitrary antibody units; N/A, not applicable; SDI, serologically determined infection.
a X: threshold days between dates of 2 sequential antibody results: s2− s1; Z: threshold rise in antibody level between s1 and s2: Ms2−Ms1;
Y: threshold days among occurrence of ADI, sa, and first sample date s1; seroconversion (seronegative to seropositive) between s1 and s2:
Ms1 < 1.5 log10(AU) and Ms2≥ 1.5 log10(AU) (Figure 1A). Boost: minimal antibody level boost between s1 and s2: Ms2−Ms1≥ Z (Figure 1, B
and C). The SDI rules considered are defined as 1) most conservative: Z = 10 fold and (X = 100 and Y = 200); 2) most pragmatic:
(seroconversion | Z = 4 fold) and (X = 120 and Y = 50); and 3) most liberal (seroconversion | Z = 2 fold) and (Y = 50).
Table 1. Parameters and Rules for Defining Classes of
Serologically Defined Infection of a Birth Cohort of 635 Children in
Kilifi, Kenya, Monitored Over the Period From January 31, 2002, to
April 22, 2005
Definition
Symbol
X Threshold days between dates of 2
sequential antibody results: s2− s1
Z Threshold rise in antibody level between
s1 and s2: Ms2−Ms1
Y Threshold days among occurrence of ADI,
sa, and first sample date s1
Serologic
changes
Seroconversion Seroconversion (seronegative to
seropositive) between s1 and s2:
Ms1 < 1.5 log10(AU) and
Ms2≥ 1.5 log10(AU)
Boost Minimal antibody level boost between s1
and s2: Ms2−Ms1≥ Z
SDI rule
Most
conservative
Z = 10 fold and (X = 100 and Y = 200)
Most pragmatic (Seroconversion | Z = 4 fold) and (X = 120
and Y = 50)
Most liberal (Seroconversion | Z = 2 fold and Y = 50)
Abbreviations: ADI, antigen determined infection; AU, arbitrary
antibody units; SDI, serologically determined infection.
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analysis was undertaken by using Stata, version 11, soft-
ware (StataCorp LP, College Station, Texas).
RESULTS
Descriptive analysis of the cohort
There were 635 children in the cohort (50.6% female)
with a total observation time of 1,208 child-years and a
median number of contacts per child of 65 (interquartile
range: 45–75; range: 1–111). A total of 409 ADIs were de-
tected in 326 children. There were 3,855 antibody measure-
ments in total from 606 children. No antibody
measurements were available for 29 children. The number
of SDIs identiﬁed in the 3 classes (most conservative, most
pragmatic, and most liberal) was 67, 189, and 382, respec-
tively. In the most pragmatic class, the 189 SDIs arose in
162 children, of whom 136 had 1 SDI, 25 had 2 SDIs, and
1 had 3 SDIs. Pooling SDI and ADI results, we found that
there were 598 infections and that these occurred in a total
of 411 children (64.7%). Of these 411 children, 259 had 1
infection, 124 had 2 infections, 23 had 3 infections, 3 had
4 infections, and 2 had 5 infections, yielding a total of 187
reinfections. The proportion of children seropositive was
97% in the age group <2 months, 63% at 3–5 months, 39%
at 6–8 months, 50% at 9–11 months, 66% at 12–17
months, 73% at 18–23 months, and 88% at 24–30 months.
Respiratory syncytial virus incidence
The crude estimate of respiratory syncytial virus inci-
dence was 495 cases per 1,000 child-years of observation
(CYO), ranging from 369/1,000 CYO in children less than
6 months of age to 649/1,000 CYO in children aged 24–30
months. Respiratory syncytial virus incidence was 552/
1,000 CYO for primary infections and 404/1,000 CYO
for reinfections. Web Table 1 (available at http://aje.
oxfordjournals.org/) summarizes incidence data across a
range of factors using SDI data deﬁned by most pragmatic,
most conservative, and most liberal deﬁnitions, respective-
ly. There is no change in the patterns, although incidences
are generally much higher for most liberal compared with
most pragmatic and much lower for most conservative com-
pared with most pragmatic.
Univariable analysis of factors associated with
respiratory syncytial virus incidence
The rate of respiratory syncytial virus infection was
reduced by 70% (hazard ratio (HR) = 0.30, 95% conﬁdence
interval (CI): 0.22, 0.41) during the ﬁrst 6 months after an
infection. There were a 40% (HR = 0.60, 95% CI: 0.50,
0.73) reduction in the rate of secondary infection compared
with the rate of primary infection and a 55% (HR = 0.45,
95% CI: 0.30, 0.66) reduction for tertiary or more infec-
tions, when compared with primary infections. The rate of
infection was lowest in the youngest age group (0–5
months) and was 1.4–2.1 fold higher for children in older
age groups relative to children 0–5 months of age (Web
Table 2). These most pragmatic results differ for other SDI
rules only in the age-group effect, where the signiﬁcant in-
crease extends to the group aged 24–30 months for the
most liberal class and is reduced to the group aged only 6–
11 months for the most conservative class (Web Table 2).
Table 3. Multivariable Cox Regression Analysis of Factors Associated With Respiratory Syncytial Virus Incidence of a Birth Cohort of 635
Children in Kilifi, Kenya, Monitored Over the Period From January 31, 2002, to April 22, 2005, for the Most Pragmatic Rule After Experiencing
Primary and Secondary Infections
Variable
Most Pragmatic Rule After Experiencing
Primary Infection
Most Pragmatic Rule After Experiencing
Secondary Infection
No. of
Infections
Adjusted
Hazard Ratio
95% Confidence
Interval
P
Value
No. of
Infections
Adjusted
Hazard Ratio
95% Confidence
Interval
P
Value
Sex
Female 319 1 Referent 109 1 Referent
Male 279 0.94 0.80, 1.11 0.48 78 0.77 0.58, 1.02 0.07
Time since last
infection,
months
411 1 Referent 152 1 Referent
0–5 35 0.30 0.21, 0.42 <0.001 15 0.41 0.22, 0.73 0.003
6–11 63 0.81 0.66, 1.43 0.88 14 1.57 0.90, 2.74 0.12
12–17 32 0.97 0.63, 1.79 0.82 5 0.99 0.40, 2.45 0.98
≥18 22 0.88 0.56, 1.39 0.59 1 0.92 0.12, 7.41 0.94
Age group, months
0–5 104 1 Referent 6 1 Referent
6–11 151 2.54 1.60, 4.03 <0.001 21 3.84 1.05, 14.08 0.042
12–17 118 2.35 1.42, 3.90 0.001 26 3.76 0.96, 14.75 0.057
18–23 142 2.24 1.30, 3.86 0.004 83 6.69 1.61, 27.90 0.009
24–30 83 1.59 0.91, 2.78 0.1 51 5.22 1.28, 21.35 0.021
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Multivariable analysis of factors associated with
respiratory syncytial virus incidence
The ﬁnal multivariate model included sex, age, number
of previous infections, and time since previous infection
and is separately presented for primary respiratory syncytial
virus infection and for secondary respiratory syncytial virus
infection (Table 3), which avoids the problem of collineari-
ty. Relative to primary incidence, the rate of secondary in-
fection was 70% lower during the ﬁrst 6 months following
ﬁrst infection and no different in any time periods beyond
(Table 3). Relative to the rate of secondary infections, the
rate of tertiary infection was 59% lower during the ﬁrst 6
months following a secondary infection and not beyond
(Table 3). Relative to primary respiratory syncytial virus in-
cidence in the age group 0–5 months, primary incidence
was over 2 times greater in all other age groups up to 18–
23 months (Table 3). Relative to secondary respiratory syn-
cytial virus incidence in the age group 0–5 months, the rate
of tertiary respiratory syncytial virus infection was 3–7 fold
higher in older age groups (Table 3). No sex differential in
the rates of infection was observed in the cohort. There was
no evidence that the model violated the proportional
hazards assumption either in general or for each ﬁtted vari-
able (Schoenfeld global test, P = 0.99). These results are
based on the most pragmatic rule for SDI but are robust to
different deﬁnitions for SDI (Web Tables 3 and 4) except
that the increased hazard of infections in older age groups
relative to young infants is less pronounced for the most
conservative class (for which speciﬁcity of infection diag-
nosis is presumed less) and more pronounced for the most
liberal class (high speciﬁcity) (Web Tables 3 and 4). Anal-
ysis using ADI alone indicated partial protection from
primary infection of 76% (95% CI: 60, 86) in the period 0–
5 months and 44% (15%–63%) in the period 6–11 months,
after infection, whereas the increased incidence in older
children relative to children 0–5 months of age was no
longer signiﬁcant.
Risk of respiratory syncytial virus-associated disease
There were 142 respiratory syncytial virus-associated
LRTI (mild and severe) cases identiﬁed in the cohort with
67 (47.2%) being severe LRTI. The risk of LRTI following
infection was 23.7% (142/598): 12.5% (75/598) for mild
LRTI and 11.2% (67/598) for severe LRTI. Following
primary infection, the risk of LRTI was 27% (111/411) and
of severe LRTI was 14.1% (58/411) (Table 4).
The risk of disease associated with primary infection was
greatest in children less than 2 months of age, that is,
44.2% (34/77) for LRTI and 31.2% (24/77) for severe
LRTI, and this declined with age to 18.8% and 3.1% in
children aged at least 24 months for LRTI and severe
LRTI, respectively (Ptrend < 0.001) (Table 4). Following re-
infection, the risk of LRTI was 16.6% and did not signiﬁ-
cantly differ by age group (Fisher’s exact test, P = 0.36),
and the risk of severe LRTI was 4.8% with no signiﬁcant
difference by age group (Fisher’s exact test, P = 0.14).
The risk of LRTI was lower for reinfection relative to
primary infection, in particular for severe LRTI (Table 5).
With adjustment for age, the decrease in disease risk in sec-
ondary infections was not statistically signiﬁcant (Table 5).
The risk of LRTI declined with increasing age at infection,
most markedly for severe LRTI (Table 6). With adjustment
for infection history, the risk of LRTI and of severe LRTI
(not mild LRTI) was reduced in children 6 months and
older relative to children under 6 months of age (Table 6).
There was a signiﬁcant trend (adjusted for infection
history) for decline with increasing age in the risks of LRTI
(P = 0.01) and severe LRTI (P < 0.001) but not of mild
LRTI (P = 0.11).
DISCUSSION
An analysis is presented of data collected from a large
and intensively monitored birth cohort with the aim of elu-
cidating key features of the natural history of respiratory
syncytial virus infection. The present study differs from
previous cohort studies (6, 8) in its examination of the rela-
tive roles of age and infection history on respiratory syncy-
tial virus reinfection rates, which have confounded earlier
work, and the investigation of the relative importance of
age and prior exposure on the risk of disease following
infection.
Table 4. Age-dependent Risk of Disease Following Respiratory
Syncytial Virus Infection of a Birth Cohort of 635 Children in Kilifi,
Kenya, Monitored Over the Period From January 31, 2002, to April
22, 2005
Age,
months
No. of
Infectionsa
Mild LRTIb SevereLRTIb LRTI
b
No. % No. % No. %
Primary infections
0–2 77 10 13.0 24 31.2 34 44.2
3–5 21 3 14.3 6 28.6 9 42.9
6–8 30 1 3.3 6 20.0 7 23.3
9–11 100 9 9.0 13 13.0 22 22.0
12–17 92 15 16.3 7 7.6 22 23.9
18–23 59 10 16.9 1 1.7 11 18.6
≥24 32 5 15.6 1 3.1 6 18.8
Total 411 53 12.9 58 14.1 111 27.0
Repeat infections
0–11 27 3 11.1 2 7.4 5 18.5
12–23 109 13 11.9 3 2.8 16 14.7
≥24 51 6 11.8 4 7.8 10 19.6
Total 187 22 11.8 9 4.8 31 16.6
Abbreviations: LRTI, lower respiratory tract infection; pO2, partial
pressure of oxygen.
a Denominator includes antigen-defined infections (ADIs) and the
“most pragmatic” class of serologically determined infections (SDI),
that is, (SDI + ADI).
b Mild LRTI was defined as children with acute cough or difficulty
in breathing and fast breathing for age; severe LRTI was defined as
children with acute cough or difficulty in breathing and one or more
of lower chest wall indrawing, hypoxia (<90% pO2), or impaired
consciousness; LRTI includes mild LRTI and severe LRTI.
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There are 3 principal results from the analysis not reported
for any previous study of respiratory syncytial virus. First,
following infection, there is a reduced rate (60%–70%) of re-
infection that is temporary (approximately of 6-month dura-
tion). Second, there is observed to be age dependence in the
rate of infection, with the incidence lowest in children <6
months of age. Third, the principal factor independently asso-
ciated with risk of LRTI and severe LRTI, following infec-
tion, is age, suggesting that the physiological changes
associated with increasing age are most important in disease
risk, rather than previous exposure.
The study was not able to provide evidence for an inde-
pendent association between the incidence of respiratory
syncytial virus infection and history of infection; that is, it
did not identify secondary respiratory syncytial virus inci-
dence to be lower than primary incidence as previously re-
ported (6). Furthermore, the evidence for a role for past
exposure (i.e., immunological in origin) in a reduced respi-
ratory syncytial virus-associated LRTI risk (shown else-
where (6, 8)) was not strong enough to be conﬁrmed
statistically in the presence of the dominant age effect.
Combined, the results above have important implications
for the design of vaccination programs. In particular, the
introduction of a vaccine that would increase the average
age at infection in those unvaccinated (i.e., through reduced
wild-type virus circulation) would have positive beneﬁts on
the risk of disease in those unvaccinated, because disease is
more strongly associated with age than with previous
Table 5. Risk of Respiratory Syncytial Virus-associated Disease by Infection History (Primary vs. Repeat
Infections) for the Birth Cohort of 635 Children in Kilifi, Kenya, Monitored Over the Period From January 31, 2002,
to April 22, 2005, With Risk Ratios Adjusted for Age Class
Disease
Severitya
No. of Primary
RSV
Infections
(n = 411)b
Risk,
%
No. of
All Repeat RSV
Infections
(n = 187)b
Risk,
%
Adjusted
RRc
95% Confidence
Interval
P
Value
Mild LRTI 53 12.9 22 11.8 0.78 0.49, 1.25 0.31
Severe
LRTI
58 14.1 9 4.8 0.58 0.29, 1.18 0.14
LRTI 111 27 31 16.6 0.72 0.50, 1.03 0.07
Abbreviations: LRTI, lower respiratory tract infection; pO2, partial pressure of oxygen; RR, risk ratio; RSV,
respiratory syncytial virus.
a Mild LRTI was defined as children with acute cough or difficulty in breathing and fast breathing for age; severe
LRTI was defined as children with acute cough or difficulty in breathing and one or more of lower chest wall
indrawing, hypoxia (<90% pO2), or impaired consciousness; LRTI includes mild LRTI and severe LRTI.
b Denominator includes antigen-defined infections (ADIs) and the “most pragmatic” class of serologically
determined infections (SDI), that is, (SDI + ADI).
c Risk ratio adjusted for age class (0–11 months, 12–23 months, and ≥24 months), comparing repeat infections
with primary infections, with 95% confidence interval.
Table 6. Risk of Respiratory Syncytial Virus-associated Disease of a Birth Cohort of 635 Children in Kilifi, Kenya, Monitored Over the Period
From January 31, 2002, to April 22, 2005, by Age Class With Risk Ratios Adjusted for Infection History
Age,
months
Total
No. of
Infectionsa
Severe LRTIb LRTIb
No. of
Infections
Risk,
%
Adjusted
RRc
95%
Confidence
Interval
P
Value
No. of
Infections Risk, %
Adjusted
RRd
95%
Confidence
Interval
P
Value
0–5 104 31 29.8 1 Referent 47 45.2 1 Referent
6–11 151 20 13.2 0.54 0.33, 0.86 0.01 30 19.9 0.53 0.38, 0.75 <0.001
12–17 118 7 5.9 0.27 0.13, 0.58 0.001 25 21.2 0.64 0.45, 0.91 0.014
18–23 142 4 2.8 0.12 0.04, 0.35 <0.001 24 16.9 0.46 0.30, 0.70 <0.001
24–30 83 5 6 0.34 0.13, 0.87 0.02 16 19.3 0.69 0.43, 1.09 0.11
Overall 598 67 11.2 0.92 0.89, 0.95 <0.001 142 23.7 0.97 0.95, 0.98 <0.001
Abbreviations: LRTI, lower respiratory tract infection; pO2, partial pressure of oxygen; RR, risk ratio.
a Includes antigen-defined infections and the “most pragmatic” class of serologically determined infections.
b Mild LRTI was defined as children with acute cough or difficulty in breathing and fast breathing for age; severe LRTI was defined as
children with acute cough or difficulty in breathing and one or more of lower chest wall indrawing, hypoxia (<90% pO2), or impaired
consciousness; LRTI includes mild LRTI and severe LRTI.
c Risk ratios adjusted for infection history, comparing the risk of severe LRTI disease by age class, with 95% confidence interval.
d Risk ratios adjusted for infection history, comparing the risk of LRTI disease by age class.
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infection. For example, vaccination of older children that
induced partial short-lived immunity (e.g., 70% for 6
months) in a signiﬁcant fraction could be beneﬁcial in
reducing disease in early infants by providing indirect pro-
tection through their ﬁrst respiratory syncytial virus
epidemic.
Serologic information has been used in previous studies
of respiratory syncytial virus infection (6, 8). Interpretation
of serologic data for diagnosis of respiratory syncytial virus
infections is complicated by 2 factors, both of which
reduce the sensitivity to detect infection. First, the presence
of maternally derived speciﬁc antibodies during the ﬁrst
few months of life has been shown to shroud the acquired
humoral response in a proportion of cases (28, 32–35). Age
dependence in the sensitivity of serology to detect infection
could lead to bias in our results, rendering the observed rel-
atively low incidence of respiratory syncytial virus in chil-
dren 0–5 months of age an artifact. Potentially offsetting
this effect is the observed inverse relation between level of
viral shedding and increasing age at respiratory syncytial
virus infection (36): Higher level shedding in early infants
might equate to increased sensitivity of the antigen assay.
Second, the acquired humoral response can be transient and
signiﬁcantly decay over a period of a few months, particu-
larly following primary infection (34). Consequently, a crit-
ical factor in such interpretation is the relation between
sampling interval and rates of antibody change, both of
which have been explored in the present analysis. Three
deﬁnitions for a serologically deﬁned infection were com-
pared with the intention of quantifying the uncertainty in
the data analysis due to antibody dynamics. Despite the
widely differing incidence estimates using most pragmatic,
most conservative, and most liberal rules (due to the differ-
ent sample sizes generated), these deﬁnitions did not
greatly inﬂuence the interpretation of the data, suggesting
no introduction of systematic bias.
The observation of the lowest incidence rate in infants
<6 months of age is supportive of other evidence for a pro-
tective effect of maternal speciﬁc antibody in young chil-
dren (37). The low incidence might also be due to low
mixing rates in this group. However, there may be a meth-
odological reason resulting from a difﬁculty in diagnosis of
infection in children in which maternal antibody is at levels
obscuring or inhibiting an immune response from infection.
This effect may be offset by the observation that, in
infants, respiratory syncytial virus infection is almost in-
variably symptomatic (8), which would have resulted in the
collection of a nasal washing for antigen detection.
The decline in risk of respiratory syncytial virus-associated
LRTI with increasing age has conventionally been attribut-
ed to accumulated immunity following previous respiratory
syncytial virus exposure, ontogeny of the immune system,
and physiological changes, such as larger airways. The
results presented here suggest that factors directly associat-
ed with the host, such as increasing size and immunologic
maturity, dominate this effect, rather than immunologic
changes resulting from pathogen exposure. The study does
not preclude an effect of exposure, only that it is less domi-
nant than the age effect within the age range and number of
exposures under study.
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